Chemovax (University of Arkansas)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameChemovax (University of Arkansas)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionLewis-Y antigen modulatorsDisialoganglioside GD2 modulators
TargetsLewis-Y antigenDisialoganglioside GD2
Therapy Area/IndicationsNeoplasm MetastasisLung NeoplasmsTriple Negative Breast Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Arkansas Foundation Realty Llc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Arkansas
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Inactive IndicationsNeoplasm MetastasisLung NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A